ArticleScientific reports2024

CCDC58 is a potential biomarker for diagnosis, prognosis, immunity, and genomic heterogeneity in pan-cancer.

Kai Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.